Severe asthma: future treatments-Reference-Cited by-同舟云学术

Severe asthma: future treatments

Published:2012-04-20 Issue:5 Volume:42 Page:706-711
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

O'Byrne P. M.¹,Naji N.¹,Gauvreau G. M.¹

Affiliation:

1. Firestone Institute for Respiratory Health; St. Joseph's Hospital and Department of Medicine; McMaster University; Hamilton; Ontario; Canada

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.2012.03965.x/fullpdf

Reference48 articles.

1. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society;Chung;Eur Respir J,1999

2. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society;American Thoracic Society;Am J Respir Crit Care Med,2000

3. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma;Bousquet;J Allergy Clin Immunol,2010

4. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI);Bel;Thorax,2011

5. The health economics of asthma and rhinitis. I. Assessing the economic impact;Weiss;J Allergy Clin Immunol,2001

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015;World Allergy Organization Journal;2023-04

2. Bronchial thermoplasty: State of the art;Respirology;2022-06-12

3. Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies;Microbiology Spectrum;2022-04-27

4. Newly diagnosed asthma in China: initial severity and changes over a 1-year management period;Annals of Translational Medicine;2022-01

5. The JAK1/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia;Biochemical Pharmacology;2021-10